PT
Menu
Search
Sections
Home
News
Analysis
Features
Comment
Data Insights
Projects
Sectors
Clinical Trials
Drug Manufacturers
Therapy Area
Cardiovascular
Central Nervous System
Immunology
Infectious Disease
Oncology
Respiratory
Themes
Artificial Intelligence
Corporate Governance
Cloud
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Insights
Deals
Jobs
Filings
Patents
Social Media
Companies
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer’s Guides
Partner Content
Pricing and Market Access
Events
Reports
Awards & Rankings
Magazine
GlobalData
About us
Advertise With Us
Contact Us
Our Marketing Solutions
GlobalData Reports
Visit GlobalData
From Our Partners
Precision medicine and digital health innovation for disease diagnosis, care and treatment
Enabling process intensification in biopharma manufacturing
Specialty drug launch strategy and operations
The next chapter of clinical trial services
Future Pharma Services
Putting quality first in the pharma supply chain
Enabling better biopharmaceutical manufacturing
Pharmaceutical Grade Silicone Manufacturer
Maximising molecule potential
News
Analysis
Sections
Features
Comment
Data Insights
Projects
Latest
Pharma Fix: The quest for the next tuberculosis vaccine
Pfizer acquires ADC pioneer Seagen for $43bn
Biotech’s post-IPO boom: rebounding from a 2022 Low?
Sectors
Sections
Clinical Trials
Drug Manufacturers
Therapy Area
Latest
Alnylam’s Manufacturing Facility, Norton, Massachusetts
China’s NMPA grants conditional approval for AstraZeneca’s Calquence
Takeda set to build $764m manufacturing facility in Japan
Themes
Sections
Artificial Intelligence
Cloud
Corporate Governance
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Latest
Takeda set to build $764m manufacturing facility in Japan
Klinge Corporation
TRiBECA® Knowledge
Insights
Sections
Deals
Jobs
Filings
Patents
Social Media
Latest
Merck reports rise in group net sales in fiscal 2022
AbbVie reports rise in full-year 2022 net revenues
Teva Pharmaceutical reports 5% fall in Q4 2022 revenue
Companies
Sections
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer’s Guides
Partner Content
Latest
Aseptic lyophilisation: Opportunities to improve quality and process monitoring with mass spectrometry
Optimising biopharma production through process intensification
Quality first: How pharma can meet injectables demand while staying compliant
Events
Reports
PT
May 12, 2017
HIPAA Security Policies and Procedures an Audits 2017
IndiaProduction
Share this article
IndiaProduction
Recommended Reports
KOL Perceptions of Ustekinumab Data Presented at ACR 2017
OpportunityAnalyzer: Uveitis – Opportunity Analysis and Fore...
OpportunityAnalyzer: Endometriosis – Opportunity Analysis an...
IT Industry Business Outlook and Procurement Report November...
Oral Mucositis Therapeutics - Pipeline Assessment and Market...
View All
Companies Intelligence
View All